申请人:Gillespie Paul
公开号:US20090156635A1
公开(公告)日:2009-06-18
The present invention relates to compounds of formula (I)
wherein Ar, Ar
2
, R
2
, R
3
, R
4
, m, p and s are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases that are associated with the activation of the glycogen synthase enzyme, such as diabetes.
本发明涉及式(I)化合物,其中Ar,Ar2,R2,R3,R4,m,p和s如描述和权利要求中所定义,以及其药学上可接受的盐。该化合物可用于治疗和/或预防与糖原合成酶酶活化有关的疾病,例如糖尿病。